2024³â 11¿ù 15ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Business

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýÈ°

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óÇ°

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Samsung Electronics Estimates mid-3 Trillion Won Negative Impact for Q4 2016 and Q1 2017 Due to Galaxy Note7 Discontinuation

Impact on operating profit expected to amount to mid-2 trillion won in Q4 and around 1 trillion won in Q1 2017
´º½ºÀÏÀÚ: 2016-10-14

Company will focus on expanding sales of Galaxy S7 and other models while enhancing product safety
 
Seoul, Korea – Oct. 14, 2016– Samsung Electronics announced today that it estimates a negative impact of approximately mid-3 trillion won in operating profit from the fourth quarter of 2016 through the first quarter of 2017, due to the discontinuation of Galaxy Note7 sales.
 
The company already allocated the expected direct cost from the discontinuation of Galaxy Note7 sales in its third quarter earnings guidance revision announced on Oct. 11, but expects the drop in revenue from the discontinued sales to continue to have a negative impact on operating profit for the next two quarters.
 
The negative impact is estimated in the mid-2 trillion won range for the fourth quarter of 2016 and at approximately 1 trillion won for the first quarter of 2017.
 
The company is releasing these estimates to inform the market on the impact of the Galaxy Note7 discontinuation.
 
Moving forward, Samsung Electronics plans to normalize its mobile business by expanding sales of flagship models such as the Galaxy S7 and Galaxy S7 edge.
 
Additionally, the company will focus on enhancing product safety for consumers by making significant changes in its quality assurance processes.
 
 



 Àüü´º½º¸ñ·ÏÀ¸·Î

New Data and Recent Approval in China Cements Galderma¡¯s Leadership in Regenerative Biostimulation
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
Güntner Appoints Michael Bauer as Global Vice President for Growth and Success
The Estée Lauder Companies¡¯ New Incubation Ventures and NYKAA Announce the BEAUTY&YOU India 2024 Winners
Technology Holdings Has Expanded Operations into Brazil, Driving Growth in Latin America
Burjeel Holdings and Response Plus Medical launch $1mn Human Energy Health and Wellbeing Award
AngloGold Ashanti Q3 2024 Earnings Release for the Three Months and Nine Months Ended 30 September 2024

 

Takeda Announces Strong First Half FY2024 Results and Raises Full Year...
NielsenIQ (NIQ) appoints Steen Lomholt-Thomsen as Chief Commercial Off...
ELIQUENT Life Sciences Announces: Rob Wojciechowski Joins Firm
Geopolitical Tensions Reshape Global Competitiveness: Insights from th...
Kinaxis Appoints President of Global Commercial Operations
ExxonMobil Announces Licensing Agreement to Expand Proprietary Rebar P...
Cascale Introduces New Membership Engagement Model, Elevates Supplier ...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚÇ¥±â 'ãæÚ¤ó¢'
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á
¾Ë¶ã°Ç¼³, »óÇ¥µî·Ï ¿Ï·á
Á¸Â÷´åÄÄ, ±Û²Ã º¯°æ »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇÑ°è¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, Æѽº 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..